There Should Be a Price to Pay for Knowingly Lying to Consumers
Why TINA.org wants the Supreme Court to address proof of harm in Lanham Act cases.
Similasan Eye Relief
Case Name (Date)
Plowden et al. v. Similasan Corp.
23-cv-2511, D. Colo.
(Sept. 2023)
Product/Service
Similasan Eye Relief products
Allegations
Marketing products as able to relieve various eye issues – including watery eyes, grittiness, redness, strain, and burning – when the company does not have FDA approval to make such drug claims and has not shown that the products are “generally recognized as safe and effective”
Status
Settled
(Final approval granted)
https://www.homeopathiceyedropsettlement.com/home
The Latest
TINA.org Action Sheds Light on SunPowerLED’s False Endorsement Claims
Letters alert agencies and organizations to company’s improper marketing.
VIN History USA’s ‘Free’ VIN Report
TINA.org discovers some roadblocks to unlocking this purportedly free offer.
Will the MLM Industry Fix Its Earnings Claims Problem?
New research points to “no.”
TINA.org Supports Citizen Petition Calling for AI Pricing Transparency
Why disclosures are key to protecting informed consumer choice and competition.